secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001193125-25-241556
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum files $20M ATM offering; ORLYNVAH launched Aug 2025 with modest sales expected
--------------------------------------------------------------------------------

- Filed prospectus supplement for ATM offering of up to $20M aggregate gross proceeds (max ~21.8M ordinary shares).
- Previously raised approximately $36.2M under same Sales Agreement with H.C. Wainwright.
- ORLYNVAH commercially launched in U.S. in August 2025; company expects modest sales in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/0001193125-25-241556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525241556/d933718d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-241556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer